This topic contains a solution. Click here to go to the answer

Author Question: The development of which class of drugs revolutionized the treatment of schizophrenia? a. MAO ... (Read 71 times)

imanialler

  • Hero Member
  • *****
  • Posts: 539
The development of which class of drugs revolutionized the treatment of schizophrenia?
 
  a. MAO inhibitors
  b. phenothiazines
  c. serotonin-reuptake inhibitors
  d. minor tranquilizers
  e. tricyclics

Question 2

Phenothiazines would be used to treat which of the following people?
 
  a. Tobey, who has schizophrenia b. Kirsten, who has bulimia
  c. Sami, who has bipolar disorder
  d. Michelle, who has an anxiety disorder e. Alfredo, who has major depression



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joshbk44

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

b

Answer to Question 2

a




imanialler

  • Member
  • Posts: 539
Reply 2 on: Jun 19, 2018
YES! Correct, THANKS for helping me on my review


shailee

  • Member
  • Posts: 392
Reply 3 on: Yesterday
Excellent

 

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library